Stocktoria
Cigna Group CI
NYSE · stock · Hospital & Medical Service Plans · website · IPO 1982-04-01
Cigna Group financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B | $160.4B | $153.6B | $48.6B | $41.8B |
| SG&A expense | $14.6B | $14.8B | $14.8B | $13.2B | $13.0B | $14.1B | $14.1B | $11.9B | $10.0B |
| Operating income | $9.2B | $9.4B | $8.5B | $8.4B | $7.9B | $8.2B | $8.1B | $4.2B | $3.9B |
| Income tax | $1.5B | $1.5B | $141.0M | $1.6B | $1.4B | $2.4B | $1.4B | $935.0M | $1.4B |
| Net income | $6.0B | $3.4B | $5.2B | — | — | — | — | — | — |
| EPS (diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 |
| Operating cash flow | $9.6B | $10.4B | $11.8B | $8.7B | $7.2B | $10.3B | $9.5B | $3.8B | $4.1B |
| Free cash flow | — | — | — | — | — | — | $8.4B | $3.2B | $3.6B |
| Cash & equivalents | $7.7B | $7.5B | $7.8B | $5.9B | $5.1B | $10.2B | $4.6B | $3.9B | $3.0B |
| Inventory | $7.3B | $6.7B | $5.6B | $4.8B | $3.7B | $3.2B | $2.7B | $2.8B | $228.0M |
| Total assets | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B | $155.5B | $155.8B | $153.2B | $61.8B |
| Total liabilities | $116.0B | $114.6B | $106.4B | $99.1B | $107.7B | $105.1B | $110.4B | $112.2B | $48.0B |
| Shareholders' equity | $41.9B | $41.2B | $46.2B | $44.7B | $47.1B | $50.3B | $45.3B | $41.0B | $13.7B |
Growth · year-over-year · Revenue CAGR 26.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +11.2% | +26.6% | +8.2% | +3.7% | +8.5% | +4.5% | +215.7% | +16.4% | — |
| Net income growth | +73.5% | -33.5% | — | — | — | — | — | — | — |
| EPS growth | +83.0% | -30.3% | -18.8% | +35.9% | -31.4% | +70.8% | +27.5% | +20.2% | — |
| Free cash flow growth | — | — | — | — | — | — | +160.2% | -10.3% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.